An overview of category 1 new drugs self-developed and approved in China from 2014 to 2018YANG Zhen-zheng, SUN You-song, WEI Li-jun, WU Xiao-tao, QIAO Si-miao, ZHENG Xiao-nan1537-1546
Discussion on intellectual property rights and patents in mergers and acquisitions of pharmaceutical enterprisesFANG Zhong-jian, CHEN Li-ping, WANG Jun-yan, LI Xiang-bin, LI Fan, WU Wei-jia, SHEN Yang-peng, LIU Yi-ping, FAN Song-hua, SHAO Ming-li1547-1552
Research on sampling and testing of centrally authorised products in European UnionXI Hao, YAO Lei, ZHU Jiong, WANG Chong1553-1560
Common problems analyses in the formulation and process research on consistency evaluation of oral solid dosage formSHI Jing, XU Zhen-yu1561-1566
Analysis of chemical compositions from Nepal Cordyceps by UPLC-Q-TOF-MSQIN Wei-han, YANG Yong, LI Qing, WANG Yun-hong, GUO Yan-lei, HUA Lei, LIU Fei1574-1581
The utilization of randomization methods and techniques in currently clinical trialCHEN Jun-chao, HE Ying-chun, CHEN Huan, WANG Jin, GAO Jia-hui, L(U) Ying-hua, ZHENG Qing-shan, LIU Hong-xia1582-1586
Biological distribution study of expanded activated lymphocytes in C57BL/6 miceHUANG Ying, GAO Yang, HUO Yan, ZHANG Cheng, GUO Xiao-kai, ZHOU Ying-nan, WANG Yu, WANG Jun-zhi1587-1592
Progress of central neuroprotective effects of TCMs and its active constituents based on PI3K/Akt signaling pathwayGU Zhi-rong, XU Ai-xia, LI Fang, QI Mei, MA Tian-xiang, GE Bin1593-1599
Discussion on quality management of phase Ⅰ clinical trials based on riskWEN Ke, CHAI Dong, WANG Jin, WANG Rui1600-1604